Science Explorer Back to mapMap
Discussion
Researcher · City Of Hope National Medical Center · United States

Allen Lin

Allen Lin publishes mostly in Hematology, Molecular Biology and Genetics, on topics such as Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments and Chronic Lymphocytic Leukemia Research.

OpenAlex
World rank
#1,135,446
of 7,710,434 ranked researchers
Rank in United States
#366,169
of 1,627,098
Works
34
Citations
1.8k
Citations per work
52.9
h-index
13
i10-index 13Top 45% in Hematology
Allen Lin

What does Allen Lin research?

Allen Lin's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (17%), Computer Science (5%).

Health Sciences: 19 works · 56.0% of their workMedicine: 19 works · 56.0% of their workHematology: 12 works · 36.0% of their workGenetics: 4 works · 12.0% of their workOncology: 1 works · 4.0% of their workRheumatology: 1 works · 4.0% of their workEverything else: 7 works · 22.0% of their workLife Sciences: 6 works · 17.0% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 17.0% of their workMolecular Biology: 6 works · 17.0% of their workPhysical Sciences: 2 works · 5.0% of their workComputer Science: 2 works · 5.0% of their workComputer Vision and Pattern Recognition: 2 works · 5.0% of their workTHEIR WORKAllen Lin34works
Life Sciences17%Physical Sciences5%Health Sciences56%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1956.0%
  2. Everything else722.0%
    1. Biochemistry, Genetics and Molecular Biology617.0%
    1. Computer Science25.0%
  1. 1Hematology36% of their works
  2. 2Molecular Biology17% of their works
  3. 3Genetics12% of their works
  4. 4Computer Vision and Pattern Recognition5% of their works
  5. 5Oncology4% of their works
  6. 6Rheumatology4% of their works

Research topics

Which keywords describe Allen Lin's research?

The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, BCR-ABL, Imatinib, Chronic Lymphocytic Leukemia, Genomic Aberrations and BET Bromodomains.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Prognostic Factors252 topics
  2. AML171 topic
  3. Acute Myeloid Leukemia171 topic
  4. BCR-ABL171 topic
  5. Imatinib171 topic
  6. Chronic Lymphocytic Leukemia81 topic
  7. Genomic Aberrations81 topic
  8. BET Bromodomains61 topic
  9. HDAC Inhibitors61 topic
  10. Histone Deacetylases61 topic
  11. PROTACs61 topic
  12. Fusion Genes41 topic
  13. Hypereosinophilic Syndrome41 topic
  14. DNA Methylation31 topic
  15. Histone Modification31 topic
  16. JAK2 Mutation31 topic
  17. Myelofibrosis31 topic

Where does Allen Lin work?

Allen Lin's main affiliation in the publication record is City Of Hope National Medical Center, United States.

How many publications and citations does Allen Lin have?

OpenAlex counts 34 works and 1,799 citations for Allen Lin, an h-index of 13, ranking #1,135,446 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Allen Lin

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Allen Lin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.